Company profile for Doron Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Doron Therapeutics is a clinical-stage biotechnology company dedicated to restoring mobility and function through advanced biologic therapies. Our lead program, MOTYS™, is a placental tissue–derived intra-articular injectable designed for knee osteoarthritis, offering anti-inflammatory, tissue-protective, and regenerative capabilities. Founded in 2023 as a spin-off with investor Bioventus, we combine cutting-edge regenerat...
Doron Therapeutics is a clinical-stage biotechnology company dedicated to restoring mobility and function through advanced biologic therapies. Our lead program, MOTYS™, is a placental tissue–derived intra-articular injectable designed for knee osteoarthritis, offering anti-inflammatory, tissue-protective, and regenerative capabilities. Founded in 2023 as a spin-off with investor Bioventus, we combine cutting-edge regenerative science with a mission to help patients move freely and live better.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2021 South Lakeshore Drive, Chapel Hill, NC 27514
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty